Kwangdong Pharmaceutical has published its first-ever sustainability report, detailing its ESG (Environmental, Social, and Governance) management status and achievements.
On June 26, the company stated, "We issued this report to systematically manage non-financial performance and enhance communication with stakeholders." The report outlines its ESG strategy and key activities under the vision of 'Innovation for Health, Sustainable Future.'
Through a materiality assessment, Kwangdong identified five core tasks: addressing climate change, strengthening ethical management, responsible board governance, ensuring and managing human rights, and improving product and packaging resource circulation. The company is expanding efforts in carbon neutrality, supply chain ESG management, human rights management, and enhancing compliance and ethical management.
To enhance the report's credibility and international alignment, Kwangdong incorporated global disclosure standards from initiatives such as the Global Reporting Initiative (GRI), Sustainability Accounting Standards Board (SASB), Task Force on Climate-related Financial Disclosures (TCFD), and the United Nations Sustainable Development Goals (UN SDGs).
In terms of governance, Kwangdong established an ESG committee under its board of directors in June. The committee, composed of three independent directors, is responsible for reviewing ESG strategies, policies, implementation plans, and performance.
A Kwangdong representative stated, "This measure aims to transparently disclose our ESG management achievements and build trust with stakeholders. We will continue to expand our social value based on responsible management."
Additionally, Kwangdong has recently established 'Ethics Day' to enhance its internal ethical management system. The company has also elevated its existing anti-corruption internal audit organization, previously known as the Anti-Corruption Subcommittee, to a Compliance Committee, strengthening its status and role. This committee will monitor compliance with ethical management and conduct related training and workshops.
These initiatives aim to prevent legal and corruption risks that may arise within the organization and foster a culture of compliance among employees, creating a transparent management environment.
A Kwangdong representative remarked, "With the establishment of Ethics Day, we will reaffirm the importance of conducting fair and responsible work and spread a culture of self-compliance throughout Kwangdong Pharmaceutical."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.